Joshua Brumm joined Crescent Biopharma as CEO in March 2025. Based in Waltham, United States.
Joshua Brumm joined Crescent Biopharma as CEO in March 2025. He has extensive experience in biotech and healthcare, having led four companies to public listings and raised nearly $3 billion in capital throughout his career. Prior to Crescent, he was President and CEO of Dyne Therapeutics and a general partner at Forbion.
Full founder directory · Investor directory · Company funding database · Fundraising library